GFH375 Monotherapy and Combination Therapy as First-Line Treatment for Advanced KRAS G12D-Mutant Non-Small Cell Lung Cancer
Clinical trial NCT07554859 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07554859
- Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-20
- Primary completion
- 2027-04-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.